N-methylsansalvamide a peptide analogues. Potent new antitumor agents

Journal of Medicinal Chemistry

Volumn 48, Issue 10, 2005, Pages 3630-3638

  Liu, Shouxin ^a,b   Gu, Wenxin ^a   Lo, Denise ^c   Ding, Xian Zhong ^c   Ujiki, Michael ^c   Adrian, Thomas E ^c   Soff, Gerald A ^c   Silverman, Richard B ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; PEPTIDE DERIVATIVE; SANSALVAMIDE A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; METHYLATION; PANCREAS CANCER; PANCREAS CELL; PROSTATE CANCER; STEREOCHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 18644371080     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm048952t     Document Type: Article

References (35)

1. Cancer Society. Cancer Statistics for 2003. www.cancer.org.
2. http://www.cancer.org/docroot/STT/stt_0.asp.
3. (a) Harvey, A. Strategies for discovering drugs from previously unexplored natural products. Drug Discovery Today 2000, 5, 294.
4. (b) Feher, M.; Schmidt, J. M. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. J. Chem. Inf. Comput. Sci. 2003, 43, 218.
5. Prasad, C. Bioactive Cyclic Peptides. Peptides 1995, 16, 151-164.
6. Amidon, G. L.; Lee, H. J. Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 1994, 34, 321-341.
7. (a) Blackburn, R. K.; Van Breemen, R. B. Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin. Drug Metab. Dispos. 1993, 21, 573-579.
8. (b) Pauletti, G. M.; Gangwar, S.; Okumu, F. W.; Siahaan, T. J.; Stella, V. J.; Borchardt, R. T. Esterase-sensitive cyclic prodrugs of peptides: Evaluation of an acyloxylalkoxy promoiety in a model hexapeptide. Pharm. Res. (NY) 1996, 13, 1615-1623.
9. (a) Wenger, R. M. Synthesis of cyclosporin and analogues: Structural and conformational requirements for immunosuppressive activity. Prog. Allergy 1986, 38, 46-64.
10. (b) Sakai, R.; Rinehart, K. L.; Kishore, V.; Kundu, B.; Faircloth, G.; Gloer, J. B.; Carney, J. R.; Namikoshi, M.; Sun, F.; Hughes, R. G.; Gravalos, D. G.; Quesada, T. G.; Wilson, G. R.; Heid, R. M. Structure-activity relationships of the didemnins. J. Med. Chem. 1996, 39, 2819-2834.
11. Belofsky, G. N.; Jensen, P. R.; Fenical, W. Sansalvamide: A New Cytotoxic Cyclic Depsipeptide Produced by a Marine Fungus of the Genus Fusarium. Tetrahedron Lett. 1999, 40, 2913-2916.
12. Hwang, Y.; Rowley, D.; Rhodes, D.; Gertsch, J.; Fenical, W.; Bushman, F. Mechanism of Inhibition of Poxvirus Topoisomerase by the Marine Natural Product Sansalvamide A. Mol. Pharmacol. 1999, 55, 1049-1053.
13. Gu, W.; Liu, S.; Silverman, R. B. Solid-Phase, Pd-Catalyzed, Silicon-Aryl Carbon Bond Formation. Synthesis of Sansalvamide A Peptide. Org. Lett. 2002, 4, 4171-4174.
14. The following are a few examples: (a) Jenkins, K. M.; Renner, M. K.; Jensen, P. R.; Fenical, W. Exumolides A and B: Antimicroalgal cyclic depsipeptides produced by a marine fungus of the genus Scytalidium. Tetrahedron Lett. 1998, 39, 2463-2466.
15. (b) Okano, T.; Sano, T.; Kaya, K. Micropeptin T-20, a novel phosphate-containing cyclic depsipeptide from the cyanobacerium Microcystis aeruginos. Tetrahedron Lett. 1999, 40, 2379-2382.
16. (c) Schmidt, E. W.; Harper, M. K.; Faulkner, D. J. Mozamides A and B, cyclic peptides from a Theonellid sponge from Mozambique. J. Nat. Prod. 1997, 60, 779-782.
17. (d) Clark, D. P.; Carroll, J.; Naylor, S.; Crews, P. An antifungal cyclodepsipeptide, cyclolithistide A, from the sponge Theonella swinhoei. J. Org. Chem. 1998, 63, 8757-8764.
18. 2, a novel anti-MRSA antibiotic produced by Lysobacter sp. J. Am. Chem. Soc. 1997, 119, 6680-6681.
19. (a) Ali, F. E.; Bennett, D. B.; Calvo, R. R.; Elliott, J. D.; Hwang, S.-M.; Ku, T. W.; Lago, M. A.; Nichols, A. J.; Romoff, T. T.; Shah, D. H.; Vasko, J. A.; Wong, A. S.; Yellin, T. O.; Yuan, C.-K.; Samanen, J. M. Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation. J. Med. Chem. 1994, 37, 769-780.
20. (b) Schmidt, R.; Kalman, A.; Chung, N. N.; Lemieux, C.; Horvath, C.; Schiller, P. W. Structure - activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence. Int. J. Pept. Protein Res. 1995, 46, 47-55.
21. (c) Rajeswaran, W. G.; Hocart, S. J.; Murphy, W. A.; Taylor, J. E.; Coy, D. H. Highly Potent and Subtype Selective Ligands Derived by N-Methyl Scan of a Somatostatin Antagonist. J. Med. Chem. 2001, 44, 1305-1311.
22. (d) Miller, S. C.; Scanlan, T. S. Site-Selective N-Methylation of Peptides on Solid Support. J. Am. Chem. Soc. 1997, 119, 2301-2302.
23. (e) Ceruso, M. A.; McComsey, D. F.; Leo, G. C.; Andrade-Gordon, P.; Addo, M. F.; Scarborough, R. M.; Donna Oksenberg, D.; Maryanoff, B. E. Thrombin receptor-activating peptides (TRAPs): Investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies Bioorg. Med. Chem. 1999, 7, 2353-2371.
24. Manavalan, P.; Momany, F. A. Conformational energy studies on N-methylated analogues of thyrotropin releasing hormone, enkephalin, and luteinizing hormone-releasing hormone. Biopolymers 1980, 19, 1943-1973.
25. (a) Grieco, P. A.; Hon, Y. S.; Perez-Medrano, A. Convergent, enantiospecific total synthesis of the novel cyclodepsipeptide (+)-jasplakinolide (jaspamide). J. Am. Chem. Soc. 1988, 110, 1630-1631.
26. (b) White, J. D.; Amedio, J. C. Total synthesis of geodiamolide A, a novel cyclodepsipeptide of marine origin. J. Org. Chem. 1989, 54, 736-738.
27. (c) Imaeda, T.; Hamada, Y.; Shioiri, T. Efficient syntheses of geodiamolide A and jaspamide, cytotoxic and antifungal cyclic depsipeptides of marine sponge origin. Tetrahedron Lett. 1994, 35, 591-594.
28. α-methylornithine derivatives. Tetrahedron Lett. 1995, 36, 55-58.
29. (e) Boger, D. L.; Chen, J. H.; Saionz, K. W. (-)-Sandramycin: Total synthesis and characterization of DNA binding properties. J. Am. Chem. Soc. 1996, 118, 1629-1644.
30. (f) Olsen, R. K. Synthesis of protected N-methyl amino acid derivatives. J. Org. Chem. 1970, 35, 1912-1915.
31. (g) Prashad, M.; Har, D.; Hu, B.; Kim, H. Y.; Repic, O.; Blacklock, T. J. An efficient and practical N-methylation of amino acid derivatives. Org. Lett. 2003, 5, 125-128.
32. (a) Attolini, M.; Boxus, T.; Biltresse, S.; Marchand-Brynaert, J. Chemoselective O-methylation of N-acylated/sulfonylated tyrosine derivatives. Tetrahedron Lett. 2002, 43, 1187-1188.
33. (b) Mues, H.; Kazmaier, U. The asymmetric chelate-Claisen rearrangement as a key step in the syntheses of nonproteinogenic amino acids. Synthesis 2001, 3, 487-498.
34. 2AlCl-promoted intramolecular ene reaction of a 1,6-dienoate: Evidence for a concerted mechanism. Helv. Chim. Acta 1984, 67, 730-738.
35. Hanford, H. A.; Wong, C. A.; Sandusky, H.; Cundiff, D.; Chandel, N.; Soff, G. A. Angiostatin4.5-mediated apoptosis of vascular endothelial cells. Cancer Res. 2003, 63, 4275-4289.